Screening GLP-1 Leads Before They Cost You

Every consult on your provider's calendar has a price tag, and most telehealth teams have never written it down.

It is the provider's time, the staff time to schedule and confirm it, and a share of the ad spend that produced the lead. When the person on the other end was never a fit for the service, never planned to pay what it costs or was not ready to do what a consult requires, all of that is gone. Nobody gets anything out of it, including the patient.

Nothing in this article is clinical or legal advice; it is education for marketers. Clinical protocols belong to your medical director. Privacy and advertising rules belong to your attorney.

What does an unqualified consult actually cost?

Write the formula down and use your own numbers:

Cost of a wasted consult = provider time + staff time + the ad cost of the lead.

The point of the formula is not precision. It is to make the cost visible. When a team sees that every no-show or poor fit has a real price, the conversation about screening stops being "will this reduce volume?" and becomes "which leads deserve a provider's hour?"

Qualification is not gatekeeping

There is a wrong way to do this. It treats screening as a way to reject people, with marketing deciding who is "good enough." That is unkind, it is outside the marketing function's job and it can create real risk.

Screening is routing, not judging. The goal is to match the right people to the right next step, and to hand your clinician a complete picture before the consult starts.

What are the three kinds of questions to ask?

Separate them clearly. Each has a different owner and a different purpose.

Logistics: can we serve you?

These are questions the business owns. Is the person in a state where your providers are licensed (see Licensing Across State Lines)? Are they an adult? Do you have a working phone number and email? Can they receive shipments? These can be handled by the form or an automated check, and they can be answered fast.

Readiness: are you set up to show up?

These are about the consult itself. Do they understand what the consult is, how long it takes and that a provider, not the website, decides next steps? Do they know what the service costs and how payment works? Can they take the call at the time they selected? Honest expectations here prevent no-shows and awkward surprises later.

Clinical: what does the provider need to see?

These are questions your medical director designs, and they feed the clinician, not marketing. For context, FDA-approved weight-management medications have defined indications and contraindications. For example, when the FDA approved Zepbound in November 2023, it described the indication as chronic weight management in adults with obesity or with overweight plus at least one weight-related condition, and listed contraindications including a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.¹ The FDA's March 2024 Wegovy approval for reducing cardiovascular risk similarly lists a boxed warning, other warnings and contraindications.²

The practical takeaway is not that your intake form should decide who qualifies. It is that clinicians need structured information to review those labels, and a good intake collects it clearly so the consult can be productive.

How do you design the screening flow?

Short, respectful and honest. A good flow feels like care, not paperwork.

Why honesty at the top raises show rate

People who understand what the consult is, hold a real appointment time and have seen the price should be more likely to attend. And the ones who are not a fit leave early, which is better for them and for you. A smaller number of better-matched consults beats a calendar full of maybes.

How do you protect patient privacy while screening?

By keeping sensitive answers in the right place.

Meta told health and wellness advertisers in late 2024 (the follow-through is in Telehealth Retargeting Under Meta's Health Rules) that it would restrict some mid- and lower-funnel events starting in January 2025, defining the category by information associated with medical conditions, specific health statuses or the provider and patient relationship.³ And the FTC's action against GoodRx alleged the company shared users' prescription and health information with advertising platforms, including uploading lists of users who had bought certain medications, and the proposed order permanently barred it from disclosing health information for advertising.⁴

What that means for your form

• Keep clinical screening answers in your secure, access-controlled intake.
• Do not pass answers, conditions or medication details into ad platform events, audience names or URL parameters.
• Name your audiences and events neutrally.
• Have an attorney review what your pixel and tracking tools can see on intake pages.

If this sounds like extra work, it is. It is also cheaper than the alternative.

How do you protect your show rate after the booking?

The booking is the start of the process, not the end.

• Confirm immediately, by email and text, with the date, time, link and provider name.
• Say what to prepare. A short list of what to have ready makes the call smoother.
• Remind twice. Once the day before and once an hour before.
• Make joining easy. One link, no app download if you can avoid it.
• Follow up quickly on no-shows (more in Show Rate Is a Revenue Metric). A kind message with a reschedule link is often enough.

How do you know it is working?

Track the cost per attended consult and the percentage of leads that reach a consult, not just cost per lead. Cost per lead is easy to lower and easy to misread, because a cheap lead that never shows up is the most expensive lead you have.

Review the reasons leads drop off at each step once a month. If many people leave at the price disclosure, that is information about your offer and your ads, not a reason to hide the price. If many people book and do not show, look at your reminders and your expectations.

My test for any health funnel is simple: could a patient and a regulator both read every step without wincing? That is the standard behind my telehealth work.

Keep building.Ekai